John Jamieson

John Jamieson is a Scientist II in Cell Therapy Process Development at Beam Therapeutics, with a robust background in research and process engineering. Previously, John served as a PhD Researcher at The Johns Hopkins University, where skills were honed in iPSC differentiation, blood-brain barrier modeling, and laboratory management. Key achievements include developing innovative in vitro models to study blood-brain barrier functionality and leading research teams. John also gained experience at Moderna Therapeutics, participating in both formulation development and process innovations, and held various engineering roles across multiple companies, including Waters Corporation and GVD Corporation. John holds a PhD in Chemical and Biomolecular Engineering from The Johns Hopkins University and a BS in Chemical Engineering from Northeastern University.